OssDsign Acquires Sirakoss

November 3, 2020

Swedish medtech company OssDsign AB acquired Scottish bone-graft developer Sirakoss Ltd for an initial USD 11 million plus milestone and royalty payments. The acquisition adds Sirakoss's Osteo3 ZP Putty (which has FDA 510(k) clearance) to OssDsign's craniomaxillofacial portfolio and supports immediate commercial activity in the US.

Buyers
OssDsign AB
Targets
Sirakoss Ltd
Sellers
Sirakoss shareholders (including Epidarex Capital)
Industry
Medical Devices
Location
Scotland, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.